A pooled analysis of the efficacy of fesoterodine for the treatment of overactive bladder, and the relationship between safety, co-morbidity and polypharmacy in patients aged 65 years or older - Wagg, A; Arumi, D; Herschorn, S (Age Ageing, 2017)
et al.